Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Celltrion Inc
•
08 Aug 2018 03:59
Celltrion: Manufacturing Risks Remain
Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...
Kemp Dolliver, CFA
414 Views
Share
bearish
•
Celltrion Inc
•
26 Jul 2018 11:26
Sell Celltrion Inc (068270 KS): Story Unravelling
UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...
Bucephalus Research Partnership
Follow
484 Views
Share
bearish
•
Hyundai Motor
•
24 Jul 2018 13:15
Updates on Korea's Chaebol Reforms - Proposed Revisions of the Fair Trade Act Were Specified
On 6 July 2018, a public hearing on proposed revisions of the Fair Trade Act was held. In my earlier insight Korean Conglomerates Likely to Embark...
Sustinvest
Follow
429 Views
Share
bullish
•
SK Inc
•
14 Jul 2018 10:38
SK Holdings (034730 KS): AMPAC Acquisition - Summary & Ramifications
SK Holdings Co Ltd (034730 KS) said in a regulatory filing that it had acquired a 100% stake in Fine Chemicals Holdings Corp. which is the parent...
Sanghyun Park
Follow
654 Views
Share
bullish
•
Samsung Biologics
•
13 Jul 2018 01:56
Samsung BioLogics (207940 KS): Korea FSC Ruling Summary & Clarifications
This Korea FSC's final ruling on Samsung Biologics Co., Ltd (207940 KS)'s accounting fraud case is very confusing. So, let me walk you...
Sanghyun Park
Follow
813 Views
Share
First
Previous
68
69
70
71
72
73
74
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x